RYTELO

Serial Number 90658752
Registration 7644739
700

Registration Progress

Application Filed
Apr 20, 2021
Under Examination
Sep 13, 2022
Approved for Publication
Jul 19, 2022
Published for Opposition
Jul 19, 2022
Registered
Jan 7, 2025

Trademark Image

RYTELO

Basic Information

Serial Number
90658752
Registration Number
7644739
Filing Date
April 20, 2021
Registration Date
January 7, 2025
Published for Opposition
July 19, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 7, 2025
Registration
Registered
Classes
005

Rights Holder

Geron Corporation

03
Address
919 E. Hillsdale Blvd., Suite 250
Foster City, CA 94404

Ownership History

Geron Corporation

Original Applicant
03
Foster City, CA

Geron Corporation

Owner at Publication
03
Foster City, CA

Geron Corporation

Original Registrant
03
Foster City, CA

Legal Representation

Attorney
Sharon R. Smith

USPTO Deadlines

Next Deadline
1989 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-01-07)
Due Date
January 07, 2031
Grace Period Ends
July 07, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

42 events
Date Code Type Description Documents
Apr 1, 2025 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Jan 7, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 7, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Dec 13, 2024 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Dec 13, 2024 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Nov 19, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Nov 18, 2024 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Nov 18, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 18, 2024 EX4G S SOU EXTENSION 4 GRANTED Loading...
Sep 13, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 13, 2024 EXT4 S SOU EXTENSION 4 FILED Loading...
Aug 9, 2024 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Aug 9, 2024 IUAF S USE AMENDMENT FILED Loading...
Feb 8, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 6, 2024 EX3G S SOU EXTENSION 3 GRANTED Loading...
Feb 6, 2024 EXT3 S SOU EXTENSION 3 FILED Loading...
Feb 6, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 10, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 8, 2023 EX2G S SOU EXTENSION 2 GRANTED Loading...
Aug 8, 2023 EXT2 S SOU EXTENSION 2 FILED Loading...
Aug 8, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 9, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 7, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Mar 7, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 7, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Feb 15, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 15, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Feb 15, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Sep 13, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jul 19, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 19, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 29, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 16, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 10, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 10, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 10, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 13, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 13, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Dec 13, 2021 GNRT F NON-FINAL ACTION E-MAILED Loading...
Dec 13, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 28, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 23, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceuticals for the treatment, diagnosis or prophylaxis of human diseases, disorders and conditions, namely, cancer, and diseases, disorders and conditions of the hematological systems
First Use Anywhere: Jun 24, 2024
First Use in Commerce: Jun 24, 2024

Classification

International Classes
005